Activated CD137 could enhance the antibody dependent cell-mediated cytotoxicity (ADCC) effect through the use of NK cells (20), promote the differentiation of effector T cells, inhibit the function of Tregs and facilitate T cells to play an anti-tumor function (21). The gene discussed is TNFRSF9; the disease is neoplasm.